Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-08-27
2000-01-04
Kelly, C. H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
552501, 552585, 552592, A01N 4500, C07J 5300, C07J 500, C07J 700
Patent
active
060110236
ABSTRACT:
Methods and compositions for preventing and treating neovascularization with steroids is disclosed.
REFERENCES:
patent: 4771042 (1988-09-01), Braughler et al.
patent: 4863912 (1989-09-01), Southren et al.
patent: 4876250 (1989-10-01), Clark
patent: 4945089 (1990-07-01), Clark et al.
patent: 4975537 (1990-12-01), Aristoff et al.
patent: 4997826 (1991-03-01), Southren et al.
patent: 5371078 (1994-12-01), Clark et al.
patent: 5407926 (1995-04-01), Clark
patent: 5679666 (1997-10-01), Clark
patent: 5719167 (1998-02-01), Doshi et al.
Crum, et al., A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment, Science, vol. 230, pp. 1375-1378 (Dec. 20, 1985).
Ingber, et al., A Possible Mechanism for Inhibition of Angiogenesis by Angiostatic Steroids: Induction of Capillary Basement Membrane Dissolution, Endocrinology vol. 119, pp. 1768-1775 (1986).
Li, et al., Angiostatic Steroids Potentiated by Sulphated Cyclodextrin Inhibit Corneal Neovascularization, Investigative Opthalmology and Visual Science, vol. 32, No. 11, pp. 2898-2905 (Oct., 1991).
Southren, et al., Intraocular Hypotensive Effect of a Topically Applied Cortisol Metabolite: 3-.varies., 5-.beta. tetrahydrocortisol, Investigative Ophthalmology and Visual Science, vol. 28, (May, 1987).
Folkman, et al., Angiostatic Steroids, Ann. Surg., vol. 206, No. 3 (1987).
Kitazawa, Increased Intraocular Pressure Induced by Corticosteroids, Am. J. Ophthal., vol. 82 pp. 492-493 (1976).
Cantrill, et al., Comparison of In Vitro Potency of Corticosteroids with Ability to Raise Intraocular Pressure, Am. J. Ophthal., vol. 79 pp. 1012-1016 (1975).
Mindel, et al., Comparative Ocular Pressure Elevation by Medrysone, Fluorometholone, and Dexamethasone Phosphate, Arch. Ophthal., vol. 98 pp. 1577-1578 (1980).
Furcht, Critical Factors Controlling Angiogenesis: Cell Products, Cell Matrix, and Growth Factors Laboratory Investigation, vol. 55, No. 5, pp. 505-509 (1986).
Cariou, et al., Inhibition of Human Endothelial Cell Proliferation by Heparin and Steroids, Cell Biology International Reports, vol. 12, No. 12, pp. 1037-1047 (Dec., 1988).
Tokida, et al., Production of Two Variant Laminin Forms by Endothelial Cells and Shift of Their Relative Levels by Angiostatic Steroids, The Journal of Biological Chemistry, vol. 264, No. 30, pp. 18123-18129 (Oct. 25, 1990).
Maragoudakis, et al., Antiangiogenic Action of Heparin Plus Cortisone is Associated with Decreased Collagenous Protein Synthesis in the Chick Chorioallantoic Membrane System, The Journal of Pharmacology and Experimental Therapeutics, vol. 251, No. 2, pp. 679-682 (1989).
Ashino-Fuse, et al., Medroxyprogesterone Acetate, An Anti-Cancer and Anti-Angiogenic Steroid, Inhibits the Plasminogen Activator in Bovine Endothelial Cells, Int. J. Cancer, 44, pp. 859-864 (1989).
BenEzra, Neovasculogenic Ability of Prostaglandins, Growth Factors, and Synthetic Chemoattractants, American Journal of Ophthalmology, vol. 86, No. 4, pp. 455-461, (Oct., 1978).
Rohen, Johanness W., Why is Intraocular Pressure Elevated in Chronic Simple Glaucoma?, Ophthalmology, vol. 90(7), pp. 758-764, (1983).
Knepper, et al., Glycosaminoglycans and Outflow Pathways of the Eye and Brain, Pediatric Neuroscience, vol. 12, pp. 240-251, (1985/86).
Folkman et al., Angiogenic Factors, Science, vol. 235, pp. 442-447 (1987).
Johnson, et al., Glaucoma: An Overview, Mayo Clin. Proc., vol. 61, pp. 59-67 (Jan. 1986).
Clark Abbot F.
Conrow Raymond E.
Alcon Laboratories Inc.
Kelly C. H.
Yeager Sally
LandOfFree
Angiostatic steroids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiostatic steroids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiostatic steroids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072768